Sharpe N - Search Results

1

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, Wiltse C, Wright TJ; MOXCON Investigators. Cohn JN, et al. Among authors: sharpe n. Eur J Heart Fail. 2003 Oct;5(5):659-67. doi: 10.1016/s1388-9842(03)00163-6. Eur J Heart Fail. 2003. PMID: 14607206 Free article. Clinical Trial.

2

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Cohn JN, Ferrari R, Sharpe N. Cohn JN, et al. Among authors: sharpe n. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82. doi: 10.1016/s0735-1097(99)00630-0. J Am Coll Cardiol. 2000. PMID: 10716457 Free article. Review.

3

Factors influencing the length of hospital stay of patients with heart failure.

Wright SP, Verouhis D, Gamble G, Swedberg K, Sharpe N, Doughty RN. Wright SP, et al. Among authors: sharpe n. Eur J Heart Fail. 2003 Mar;5(2):201-9. doi: 10.1016/s1388-9842(02)00201-5. Eur J Heart Fail. 2003. PMID: 12644013 Free article.

4

The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction.

Swedberg K, Sharpe N. Swedberg K, et al. Among authors: sharpe n. Eur Heart J. 1996 Sep;17(9):1306-11. doi: 10.1093/oxfordjournals.eurheartj.a015063. Eur Heart J. 1996. PMID: 8880014 Review. No abstract available.

5

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials.

Doughty RN, Rodgers A, Sharpe N, MacMahon S. Doughty RN, et al. Among authors: sharpe n. Eur Heart J. 1997 Apr;18(4):560-5. doi: 10.1093/oxfordjournals.eurheartj.a015297. Eur Heart J. 1997. PMID: 9129883 Review.

6

Optimization of ACE inhibitor therapy in heart failure.

Doughty RN, Sharpe N. Doughty RN, et al. Among authors: sharpe n. Eur Heart J. 2002 Sep;23(17):1322-3. doi: 10.1053/euhj.2002.3225. Eur Heart J. 2002. PMID: 12191742 No abstract available.

7

Cardiovascular aging and heart failure.

Oxenham H, Sharpe N. Oxenham H, et al. Among authors: sharpe n. Eur J Heart Fail. 2003 Aug;5(4):427-34. doi: 10.1016/s1388-9842(03)00011-4. Eur J Heart Fail. 2003. PMID: 12921803 Free article. Review.

8

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study.

Doughty RN, Wright SP, Pearl A, Walsh HJ, Muncaster S, Whalley GA, Gamble G, Sharpe N. Doughty RN, et al. Among authors: sharpe n. Eur Heart J. 2002 Jan;23(2):139-46. doi: 10.1053/euhj.2001.2712. Eur Heart J. 2002. PMID: 11785996 Clinical Trial.

9

Uptake of self-management strategies in a heart failure management programme.

Wright SP, Walsh H, Ingley KM, Muncaster SA, Gamble GD, Pearl A, Whalley GA, Sharpe N, Doughty RN. Wright SP, et al. Among authors: sharpe n. Eur J Heart Fail. 2003 Jun;5(3):371-80. doi: 10.1016/s1388-9842(03)00039-4. Eur J Heart Fail. 2003. PMID: 12798837 Free article. Clinical Trial.

10

Beta-blockers in heart failure. Future directions.

Sharpe N. Sharpe N. Eur Heart J. 1996 Apr;17 Suppl B:39-42. doi: 10.1093/eurheartj/17.suppl_b.39. Eur Heart J. 1996. PMID: 8733070 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page